HSP90 Expression Associated with HER2 Overexpressing Breast Ductal Carcinomas in African American Women

被引：0
|
作者：
Khan, Farhan [1 ]
Ricks-Santi, Luisel [2 ]
Hudson, Tamaro [1 ]
Beyene, Desta [1 ]
Naab, Tammey [1 ]
机构：
[1] Howard Univ Hosp, Washington, DC USA
[2] Hampton Univ, Hampton, VA 23668 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2016年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
297
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation
    Citri, A
    Gan, J
    Mosesson, Y
    Vereb, G
    Szollosi, J
    Yarden, Y
    EMBO REPORTS, 2004, 5 (12) : 1165 - 1170
  • [32] HSP90 inhibition in HER2-positive breast cancer cells
    Qadir, Z.
    Crown, J.
    Jensen, M. R.
    Clynes, M.
    Slamon, D.
    O'Donovan, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas
    Taniyama, Kiyomi
    Ishida, Katsunari
    Toda, Tamaki
    Motoshita, Junichi
    Kuraoka, Kazuya
    Saito, Akihisa
    Tani, Yoichi
    Uike, Toshinori
    Teramoto, Seiichi
    Koseki, Masato
    BREAST CANCER, 2008, 15 (03) : 231 - 240
  • [34] SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer.
    Chandarlapaty, S.
    Ye, Q.
    Huang, K.
    Fadden, P.
    Rosen, N.
    Solit, D.
    EJC SUPPLEMENTS, 2006, 4 (12): : 165 - 165
  • [35] Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas
    Kiyomi Taniyama
    Katsunari Ishida
    Tamaki Toda
    Junichi Motoshita
    Kazuya Kuraoka
    Akihisa Saito
    Yoichi Tani
    Toshinori Uike
    Seiichi Teramoto
    Masato Koseki
    Breast Cancer, 2008, 15
  • [36] Cytoplasmic Beta-Catenin Expression Associated with Triple Negative and HER2 Positive Breast Cancer Subtypes in African-American Women
    Esnakula, A. K.
    Ricks-Santi, L. J.
    Kannan, Y. M.
    Naab, T. J.
    MODERN PATHOLOGY, 2012, 25 : 37A - 38A
  • [37] Cytoplasmic Beta-Catenin Expression Associated with Triple Negative and HER2 Positive Breast Cancer Subtypes in African-American Women
    Esnakula, A. K.
    Ricks-Santi, L. J.
    Kannan, Y. M.
    Naab, T. J.
    LABORATORY INVESTIGATION, 2012, 92 : 37A - 38A
  • [38] Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors
    Chen, Calvin Yu-Chian
    JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2010, 41 (02) : 143 - 149
  • [39] Cell surface hsp90 interacts with the extracellular domain of her2 and contributes to receptor activation
    Sidera, K.
    Gaitanou, M.
    Matsas, R.
    Patsavoudi, E.
    FEBS JOURNAL, 2006, 273 : 95 - 95
  • [40] The effects of HER2 monoclonal antibody in women with HER2-overexpressing metastatic breast cancer
    Boer R.
    Breast Cancer Research, 1 (1)
12345